During the past decade, Ocala Kidney Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ocala Kidney Group" are "Restenosis" (2 trials), "Stenosis" (2 trials), "Hyperphosphatemia" (1 trials) and "Kidney Failure" (1 trials). Many other conditions were trialed in "Ocala Kidney Group" in a lesser frequency.

Most popular intervention types in "Ocala Kidney Group" are "Device" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Covera Vascular Covered Stent following PTA" (1 trials), "Covera(TM) Vascular Covered Stent" (1 trials), "Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon" (1 trials) and "ferric citrate, ca acetate, sevelamer carbonate, placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocala Kidney Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ocala Kidney Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ocala Kidney Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ocala Kidney Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".